Alnylam Pharmaceuticals Inc (ALNY)
145.07
-0.25
(-0.17%)
USD |
NASDAQ |
Apr 18, 16:00
145.07
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Cash from Financing (TTM): 172.13M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 172.13M |
September 30, 2023 | 196.34M |
June 30, 2023 | 460.22M |
March 31, 2023 | 437.17M |
December 31, 2022 | 425.75M |
September 30, 2022 | 654.61M |
June 30, 2022 | 931.42M |
March 31, 2022 | 1.231B |
December 31, 2021 | 1.247B |
September 30, 2021 | 1.173B |
June 30, 2021 | 633.08M |
March 31, 2021 | 992.29M |
December 31, 2020 | 994.98M |
September 30, 2020 | 817.37M |
June 30, 2020 | 762.52M |
March 31, 2020 | 486.12M |
December 31, 2019 | 823.18M |
September 30, 2019 | 788.22M |
June 30, 2019 | 821.91M |
March 31, 2019 | 414.88M |
December 31, 2018 | 65.47M |
September 30, 2018 | 767.04M |
June 30, 2018 | 782.97M |
March 31, 2018 | 1.164B |
December 31, 2017 | 1.125B |
Date | Value |
---|---|
September 30, 2017 | 421.02M |
June 30, 2017 | 396.46M |
March 31, 2017 | 164.48M |
December 31, 2016 | 177.83M |
September 30, 2016 | 181.22M |
June 30, 2016 | 180.52M |
March 31, 2016 | 33.26M |
December 31, 2015 | 616.18M |
September 30, 2015 | 617.37M |
June 30, 2015 | 618.51M |
March 31, 2015 | 616.57M |
December 31, 2014 | 736.46M |
September 30, 2014 | 736.46M |
June 30, 2014 | 742.75M |
March 31, 2014 | 741.59M |
December 31, 2013 | 200.93M |
September 30, 2013 | 194.24M |
June 30, 2013 | 187.66M |
March 31, 2013 | 184.30M |
December 31, 2012 | 93.41M |
September 30, 2012 | 92.71M |
June 30, 2012 | 88.21M |
March 31, 2012 | 88.05M |
December 31, 2011 | 0.738M |
September 30, 2011 | 0.998M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
172.13M
Minimum
Dec 2023
1.247B
Maximum
Dec 2021
739.37M
Average
788.22M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
Ionis Pharmaceuticals Inc | 644.08M |
Pfizer Inc | 26.07B |
Blueprint Medicines Corp | 119.22M |
Madrigal Pharmaceuticals Inc | 595.12M |
Sarepta Therapeutics Inc | 125.00M |